BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36423543)

  • 1. Development of in vitro and in vivo tools to evaluate the antiangiogenic potential of melatonin to neutralize the angiogenic effects of VEGF and breast cancer cells: CAM assay and 3D endothelial cell spheroids.
    Laborda-Illanes A; Sánchez-Alcoholado L; Castellano-Castillo D; Boutriq S; Plaza-Andrades I; Aranega-Martín L; Peralta-Linero J; Alba E; González-González A; Queipo-Ortuño MI
    Biomed Pharmacother; 2023 Jan; 157():114041. PubMed ID: 36423543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
    Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
    Gao W; Jin K; Lan H; Han N; Cao F; Teng L
    Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Anti-Angiogenic and Anti-Proliferative Activity of Methyl Hydroxychalcone.
    Sahib HB
    Asian Pac J Cancer Prev; 2022 Jun; 23(6):2071-2077. PubMed ID: 35763650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epigallocatechin gallate derivative Y
    Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
    J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro.
    Heiss M; Hellström M; Kalén M; May T; Weber H; Hecker M; Augustin HG; Korff T
    FASEB J; 2015 Jul; 29(7):3076-84. PubMed ID: 25857554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy.
    Rezzola S; Nawaz IM; Cancarini A; Ravelli C; Calza S; Semeraro F; Presta M
    Angiogenesis; 2017 Nov; 20(4):629-640. PubMed ID: 28905243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acacetin inhibits in vitro and in vivo angiogenesis and downregulates Stat signaling and VEGF expression.
    Bhat TA; Nambiar D; Tailor D; Pal A; Agarwal R; Singh RP
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1128-39. PubMed ID: 23943785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
    Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
    Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44+/CD24- breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties.
    Sun H; Jia J; Wang X; Ma B; Di L; Song G; Ren J
    Clin Transl Oncol; 2013 Jan; 15(1):46-54. PubMed ID: 22855175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel bisindole-PBD conjugate inhibits angiogenesis by regulating STAT3 and VEGF in breast cancer cells.
    Sarma P; Ramaiah MJ; Pal D; Bhadra U; Pal Bhadra M
    Life Sci; 2016 Apr; 151():264-276. PubMed ID: 26979778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-deoxy-d-ribose (2dDR) upregulates vascular endothelial growth factor (VEGF) and stimulates angiogenesis.
    Dikici S; Bullock AJ; Yar M; Claeyssens F; MacNeil S
    Microvasc Res; 2020 Sep; 131():104035. PubMed ID: 32593538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oroxyloside inhibits angiogenesis through suppressing internalization of VEGFR2/Flk-1 in endothelial cells.
    Zhao K; Li X; Lin B; Yang D; Zhou Y; Li Z; Guo Q; Lu N
    J Cell Physiol; 2018 Apr; 233(4):3454-3464. PubMed ID: 28926106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
    Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
    J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-8 Favors VEGF-Induced Angiogenesis:
    Varinská L; Fáber L; Petrovová E; Balážová L; Ivančová E; Kolář M; Gál P
    Anticancer Res; 2020 Jun; 40(6):3191-3201. PubMed ID: 32487613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular disrupting activity of combretastatin analogues.
    Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
    Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.